In 2025, the "drug" is no longer just the chemical; it is the "delivery system." The integration of Smart Inhalers—devices equipped with Bluetooth sensors that track when and how a patient takes their medication—is transforming respiratory care. These devices sync with a patient’s smartphone to provide real-time nudges and technique corrections, addressing the #1 failure in respiratory medicine: poor inhaler technique.

The Respiratory Drugs Market report notes that the digital respiratory devices market is projected to reach USD 304 billion by 2030, reflecting a massive shift toward IoT-enabled care. In 2025, many insurance providers in the US and EU have begun mandating the use of smart inhalers for "high-risk" patients. The data generated allows doctors to see if a patient is over-relying on "rescue" inhalers, a clear early-warning sign of an impending attack.

This "Digital-Drug Duo" is particularly effective in pediatric asthma. Gamified apps connected to smart inhalers reward children for consistent usage, significantly reducing emergency room visits. By 2026, it is expected that 25% of all branded respiratory prescriptions will come bundled with a digital adherence component, moving the industry toward a "software-enabled pharmaceutical" model.

Related Reports